Clinical Trials Directory

Trials / Unknown

UnknownNCT02952183

Efficacy of Pelvic Autonomic Nerve Monitoring System (PAMS I) in Female Patients With Pelvic Tumors

Exploratory Study for Evaluating the Efficacy of Pelvic Autonomic Nerve Monitoring System (PAMS I) in Female Patients With Pelvic Tumors (FUSION Trial V)

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Although nerve-sparing surgery has been introduced for female patients with the pelvic tumors, its success rate depends on operators. To achieve consistency of surgical procedure, It is necessary to adopt pelvic autonomic nerve monitoring technique. The Aims of this study is 1. Development of pelvic autonomic nerve monitoring system (PAMS I) by using urodynamic system. 2. Evaluation of autonomic nerve sparing by intraoperative monitoring with PAMS I 3. Evaluating the efficacy of PAMS I by intraoperative neurophysiological monitoring (IOM)

Detailed description

After surgery for pelvic tumor, most of patients complain voiding dysfunction, defecation dysfunction and sexual dysfunction which lead to decrease quality of life. Recently, nerve-sparing surgery has been introduced. But it is difficult to establish standard surgical procedure for nerve-sparing. And it is the concern that performing nerve sparing surgery may reduce radicality of surgery which influence prognosis. Through pelvic autonomic nerve monitoring system (PAMS I), this trial is expected to raise the possibility of nerve-sparing with maintaining radicality of surgery. Pressure sensor of PAMS I and needle prove of IOM are very thin and these instruments have been used clinically. Taking this into consideration, additional risk by nerve monitoring is considered to be minimal.

Conditions

Interventions

TypeNameDescription
DEVICEPAMS IAfter general anesthesia, pressure sensor of PAMS I is placed into bladder, vagina and rectum. Then pressure change is monitored during performing pelvic autonomic nerve dissection. Both PAMS I and IOM will be used for monitoring.

Timeline

Start date
2015-07-01
Primary completion
2018-08-01
First posted
2016-11-02
Last updated
2016-11-02

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02952183. Inclusion in this directory is not an endorsement.